Skip to main content

Table 4 Multivariate analysis for the end point (all-cause mortality)

From: Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy

  Univariate analysis Multivariate analysisa)
HR 95% CI P-value HR 95% CI P-value
Male 2.6 1.2–5.7 0.01 1.8 0.8–4.0 0.14
EF ≤ 35% 4.8 2.2–104 < 0.01 3.6 1.6–8.1 < 0.01
Emotionalerstress 0.4 0.1–1.1 0.10    
Inotropic drugs 3.9 1.9–7.9 < 0.01 2.2 1.0–4.8 0.04
Diabetes mellitus Typ II 1.0 0.7–1.4 0.81    
Hypertension 0.9 0.7–1.2 0.64    
Apical ballooning 1.1 0.8–1.4 0.39    
History of cancer 1.7 0.7–4.2 0.21    
Smoking 0.7 0.3–1.6 0.49    
  1. HR hazard ratio, EF ejection fraction, CRP c-reactive protein, GFR glomerular filtration rate
  2. aOnly the following variables with significant effects in univariate analysis were analyzed by multivariate Cox regression: Male, EF ≤ 35%, Inotropic drugs
  3. The bolded indication highlight significant values